Ex vivo competition between hepatic arterial and portal venous flow
ing as a result of the decreasing Vr HA . Q PV restored either spontaneously or by lowering P HA . this phenomenon was defined as flow competition evoked by an increasing Q HA and observed during HMP of porcine livers as well as a human liver discarded for clinical transplantation, which illustrates that the observation was not species-specific. this increasing Q HA was associated with a progressive decrease of Q PV . Hereby, the inflow P HA was remarkably higher compared to the P PV . the flow competition was completely reversible when P HA was reduced. the aim of this study was to evaluate whether this phenomenon of flow competition could be reproduced in an animal model. to this end, two hypotheses concerning the induction of flow competition between the HA and PV during liver HMP were tested. Since an elevated pressure in the sinusoids reduces the pressure difference between the PV and the sinusoids, and consequently reduces Q PV , we hypothesized that Q PV is hampered as a consequence of an elevated sinusoidal pressure. to test this hypothesis, we evaluated whether an increased pressure at the sinusoidal level could evoke the previously observed flow competition during HMP. First, an increased intra-sinusoidal pressure was evoked by an increased P HA (livers [1] [2] [3] [4] [5] . Secondly, as a proof of concept that an increased sinusoidal pressure might indeed affect the flow behavior, a moderate or severe obstructed hepatic outflow at the level of the suprahepatic vena cava inferior (VcI) was applied to evoke flow competition (livers [3] [4] [5] . In addition, the reversibility of the flow competition was investigated. In contrast, the opposite flow competition (by increasing P PV ) was not examined in this study. due to the particular compliance (high flow, low resistance) of the portal vasculature, a rise in P PV , would not immediately result in a substantial increase of the Q PV . Furthermore, a substantial increase of P PV to overcome the P HA would result in an extremely high Q PV way out of the physiological range.
MAtErIALS And MEtHodS
Animal model and liver procurement this study was approved by the local animal care committee of the university Hospitals Leuven (Belgium). All experiments were carried out in accordance with the federal guidelines (10) . Five porcine livers (average weight 600 g, rameters could help transplant surgeons to discard grafts destined to fail after transplantation. HMP has also been suggested to better preserve livers from Ecds (5) . these livers convey a higher risk of early graft dysfunction and primary graft non-function, jeopardizing the outcome for the recipient, especially in the absence of liver dialysis and/ or an emergency re-transplantation. contrary to the kidney, HMP has not yet become common clinical practice in liver transplantation. Several factors contribute to this, such as the complex anatomical and functional features of the liver compared to the kidney. At present, ideal HMP settings for livers remain to be defined. these should consist of an optimal combination of parameters such as the route of perfusion (hepatic artery (HA), portal vein (PV), or both), the concomitant fluid dynamics (continuous or pulsatile perfusion and the optimal pressure/flow rates), the perfusion solution, the applied temperature, and whether or not to administer oxygen (6) . Previously, we studied hepatic flow characteristics during HMP feasibility studies on porcine livers (7-9) and human livers discarded for clinical transplantation. the default temperature and perfusion solution settings were initially similar to those commonly applied for renal HMP. Both the HA and PV were continuously perfused with a higher perfusion pressure (P) at the HA compared to the PV. In line with the LifePort™ technology (organ recovery Systems, chicago, uSA) currently employed for clinical renal HMP and for the liver HMP prototype used in our center, the perfusion flow (Q) through the organ is secondary to the pressure, which is set by the operator. therefore, HMP is pressure-driven. during our initial experience with liver HMP using Lifeport™ technology, vascular resistance (Vr) was found to be consistently higher in the HA compared to the PV. during perfusion, Vr HA gradually decreased (similar to observations in the kidney), resulting in an increasing Q, since P was kept constant (design and operator controlled). this decrease of Vr during HMP is thought to reflect the relaxation of the peri-vascular smooth muscle cells present in the vessels of the HA vascular bed, which are much less developed in the PV. to limit the potential shear stresses exerted on the endothelium by a high flow of a cold (4-6°c) viscous perfusion fluid in the PV (Q PV ), a flow limitation feature was added to the operating facilities of the HMP liver device. during some HMP feasibility machine perfusion experiments, a progressive decrease and/or a complete cessation of the Q PV was observed while Q HA was increas-clamped. All livers were then perfused using the default settings for clinical HMP of kidneys, as adapted for livers in our department (11) . Livers were perfused with 2 liters of non-oxygenated 4-6°c KPS-1™. this perfusion solution is routinely used for renal HMP and is similar to the solution originally designed by Belzer (12) . A specially designed prototype device for liver HMP, the Liver worksta-tion™ (organ recovery Systems, chicago, uSA), allowed for pressure-controlled, flow-unlimited continuous perfusion through the HA and pressure-controlled, flow-limited continuous perfusion through the PV (Fig. 1 ). Q PV was limited to 0.5 mL/g per minute (resulting in approximately 300 mL/min for an average liver weight of 600 g). this flow limitation feature was implemented in our setting because it was previously observed that P PV control alone, even at low temperatures, gave rise to very high flow rates (e.g. >2 mL/g per minute, (7) ). Such high flows could induce significant shear stress during HMP, damaging the sinusoidal endothelial cell lining. Similarly, in porcine HMP protocols, flows between 0.4-0.6 mL/g per minute have been reported (13, 14) . during HMP, livers were placed in a domeshaped cassette, and partially immersed in KPS-1™ ( Fig.  1) . Moreover, the device was designed to regularly wash-from 30-35 kg pigs) were procured according to the standard methods of liver retrieval which are routinely applied in our lab (11) . Pigs were fastened during 12 hours prior to surgery with unlimited access to water. under general anesthesia, livers were freed from their peritoneal attachments, the common bile duct was ligated, and the PV, the infra-renal aorta and VcI were prepared for cannulation. Livers were washed-out with 5 liters of 4°c Histidinetryptophane-Ketoglutarate solution retrogradely via the aorta into the HA, and antegradely via the PV. the supradiaphragmatic aorta and supra-hepatic VcI were clamped. the insertion of a large cannula in the infra-renal VcI allowed the removal of all blood and Histidine-tryptophane-Ketoglutarate solution after hepatic wash-out. Afterwards, the liver was removed and prepared for HMP.
Hypothermic machine perfusion
Livers were prepared for HMP by cannulation of the PV and the HA with an atraumatic "straight-in" cannula. the HA was left in continuity with an aortic conduit. Subsequently, a large diameter outflow drain was positioned in the infra-hepatic VcI, while the supra-hepatic VcI was At this level, perfusion fluid supplied by the hepatic arterioles and portal venules enters the periphery of hepatic functional units (the lobules) and mixes in the hepatic-specific capillaries (the sinusoids). Consequently, the mixture is drained radially until it reaches the central vein. Afterwards, the central venules cluster until the fluid reaches the hepatic veins at the outflow of the liver (25) . A large drain is placed in the infra-hepatic vena cava inferior which drains the outflow of the liver (blue). Once the fluid left the liver, it is recirculated. Throughout the HMP experiments, pressures and flows are measured at the level of the HA and PV cannulas. In normal conditions, the HA is typically characterized by a high pressure and low flow, while the PV is characterized by a low pressure and high flow.
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Experimental design
Following appropriate insertion of the cannulas into the vessels and positioning of the porcine livers (n=5) in the organ cassette, HMP was initiated applying the following conditions: P PV ≤7 mmHg and Q PV ≤300 mL/min for the PV inlet, and P HA =25 mmHg with unlimited Q HA for the HA inlet. After the initiation of HMP perfusion, a stable perfusion regime was awaited (approximately 1 hr) before starting the experimental measurements until the arterial vascular resistance no out the tubing for a short period (10 seconds every 10 minutes). during these periods, the organ is not perfused and the pressure drops. After this wash-out time, the perfusion restarts and the pressure builds up again. Pressure was measured at the inflow of the HA (P HA ) and PV (P PV ), immediately proximal to the vessels using a pressure sensor and transducer integrated into the HMP device (Honeywell part no 26PcBFB6G±5 psi, Honeywell, columbus, ohio, uSA). the accuracy of these pressure measurements was acquired before every experiment through a second measurement using an external pressure monitor (Siemens Sc 7000, dräger Medical, telford, PA, uSA) which was calibrated before use. Moreover, pressure measurements were first set to zero at the ambient air pressure. Pressure at the supra-hepatic VcI (P VcI ) was measured using the external pressure sensor, connected to the external monitor. Flow rates in the HA and PV were measured separately and expressed as mL/min. these measurements were obtained by multiplying the rotations per minute of the roller pump by the volume delivered per revolution. Previously, it was found that the volume delivered per revolution is constant as long as the pump tubing is not used more than 48 hours. the flow rate was measured by a tachometer on the pump motor using a digital pulse-counting method to record angular position and speed of the pump. the tachometers were integral parts of the applied roller pumps (watson-Marlow Alitea, Stockholm, Sweden) on the HMP machine. the accuracy of the flow measurements was checked by calibration of the flow prior to every experiment. this was done by comparing the calculated flows based on the rotation speed of the pumps with the flows acquired by physically collecting the volume of perfusate pumped per unit of time prior to the measurements. data acquisition was done continuously throughout the experiment, with a sampling frequency of 1 Hz. Based on P HA , P PV , and the flow rates of the rotor pumps, Vr was calculated as P/Q and expressed as mmHg*min per milliliter for the HA and PV. Post-processing of the acquired data was done using the software packages Excel (Microsoft, redmond, wA, uSA) and Sigmaplot (Systat Software Inc, San Jose, cA, uSA). the data presented in the figures and tables of this paper are the raw and unfiltered data. and Q PV . P HA was incrementally increased every 10 minutes starting from 25 mmHg. This resulted in an incremental Q HA increase. Meanwhile, a Q PV flow limit (±330 mL/ min) was set by the operators while the maximal P PV was set at 7 mmHg. A P HA of 50 mmHg (arrow at t=37 min) evoked a series of decreasing but initially self-restoring Q PV . These flow oscillations occur as the precursors of a flow instability. Eventually, Q PV was hampered, indicating the initiation of the flow competition (arrow at t=75 min), resulting in a complete cessation of Q PV . To reverse the flow competition P HA was lowered to 45 mmHg (arrow at t=95 min). Portal flow was gradually restored by also increasing the P PV (arrow at t=103 min). Further decreasing the P HA (arrow at t=135 min), resulted in a decreased Q HA , allowing the full restoration of Q PV .
HMP initiation, a stable hepatic flow was established to illustrate the competition in each of the five porcine livers either (a) by increasing P HA or (b) by obstructing the VcI outflow. longer decreased over time. two experimental settings were designed to increase the sinusoidal pressure and to study whether flow competition could be evoked. After when the limits of the perfusion device were encountered. whenever flow competition was observed, the reversibility was consequently investigated by a stepwise decrease of the P HA (Fig. 2) .
b) Increased outflow resistance at the level of the infrahepatic VCI
An outflow obstruction was evoked by clamping the outflow cannula inserted into the VcI. this outflow obstruction was done in a controlled way while moni-a) Incremental increase of HA inflow pressure/flow the initial P HA was set at 25 mmHg and incrementally increased (steps of 10 mmHg) once a stable Q was achieved following a given change in P HA . the P HA was increased incrementally until a significant decrease in Q PV was observed, resulting in a flow competition (tab. I and Fig. 2 ). In the case the maximal Q HA (300 mL/min, as determined by the design of the pumps) was reached during the incremental increase of P HA , the P PV was gradually decreased. this was done to evoke flow competition For moderate outflow obstruction, data are given at the moment just before, during and after the obstruction. In this case, Q HA decreased while Q PV remained stable despite the increased vascular resistance, indicated by a higher P PV . After the obstruction, Q HA returned to the initial values (see also Fig. 3) . In contrast, a repetitive and alternating increase/decrease between Q HA and Q PV was observed during the severe obstruction. First, a decreasing Q PV was observed, while Q HA increased, followed by a spontaneous restoration of Q PV with a decreasing Q HA (see Fig. 3 to increase the pressure from a normal value of <1 mmHg to 7-9 mmHg. In a second experimental setting, a higher resistance at the outflow was created by a subtotal clamp on the outflow tube. this "severe" obstruction resulted in a rise of the pressure at the VcI of >9 mmHg while complete cessation of the hepatic flow was avoided.
rESuLtS
a) Incremental increase of HA inflow pressure/flow
In 2 out of 5 experiments (tab. I, livers 1 and 3), increasing the P HA from 25 to 55 mmHg and from 25 to 70 mmHg resulted in an increase of the Q HA (from 91 to 231 mL/min and from 78 to 281 mL/min, respectively), evoking a gradual flow competition resulting in a Q PV cessation at the highest P HA . In 2 other experiments (tab. I, livers 4 and 5; Fig. 2 ), a Q HA of approximately 300 mL/min was reached (P HA of 49 and 51 mmHg, respectively) without a significant decrease in Q PV . this is the maximal Q that could be generated by the applied pump. Subsequently, flow competition with Q PV cessation could then be evoked by lowering the inflow P PV to 1 mmHg. of note, only a substantial decrease of P PV resulted in a significant decrease of Q PV , since a P PV of 7 mmHg is never reached due to the flow limitation feature added. Flow competition could be reversed by lowering P HA (livers 1 and 3) or additionally increasing P PV (livers 4 and 5). during the experiment with liver 2, the evoked flow competition was not fully reversible (tab. I) since it occurred intermittently and continuously after a spontaneous restoration. As such, the Q PV never stopped completely (indicated in tab. I by a mean value >0 mL/min).
b) Increased outflow/back pressure at the level of the infra-hepatic VCI
Subsequent to the flow competition experiments, a stable P/Q condition, similar to the start conditions, was waited for and ensured (P PV ≤7 mmHg, Q PV ≤300 mL/min, P HA =25 mmHg and Q HA unlimited). this resulted in a P VcI ≤1 mmHg. A moderate outflow obstruction first resulted in a gradual decrease of Q HA , until a constant flow was reached, while Q PV remained stable ( Figs. 3A and B , tab. II). After removal of the moderate outflow obstruction, Q HA was restored to the (pre-outflow obstruction) start values.
toring the pressure at the VcI. two different situations were created (3 experiments for each situation). In a first set of experiments, the outflow cannula was clamped to obtain a "moderate" obstruction aiming
Fig. 3 -Time-dependent measurements of flow competition evoked by the incremental increase of sinusoidal pressure caused by a moderate or severe outflow obstruction at the VCI (liver 4). Panels A and B display the HA and PV pressure and flow measurements, respectively. When initiating a moderate obstruction (arrow at t=3 min), Q HA decreased until the outflow obstruction was stopped (arrow at t=17 min). Meanwhile, Q PV as well as P HA and P PV remained approximately constant. After the initiation of a severe obstruction (arrow at t=68 min), an alternating increase/decrease between Q HA and Q PV was evoked, until the outflow obstruction was removed (arrow at t=87 min). Panels C and D are close-ups (t=78-90 min) of a part
of the severe obstruction. The results showed a repetitive pattern of alternating increases and decreases between Q HA and Q PV . After the initiation of severe outflow obstruction, a decrease in Q PV was observed with a concomitant Q HA increase. Subsequently, the Q PV recovered spontaneously and Q HA decreased. This pattern of mutual flow competition (illustrated by the arrows in panel D) was repeated until the severe obstruction was removed. The fluctuations were also detectable in the P HA and P PV measurements.
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Studies shown in this table are references (13) and . the perfusion conditions include: species, HA and PV perfusion settings, temperature, perfusion period, pressure or flow control. c = continuous; P = pulsatile. neural regulation is suggested to be of little importance for the hepatic blood flow, contrary to the numerous effects of humoral regulation (e.g. no, co), and the effects of some drugs such as volatile anesthetics, β-adrenergic stimulants, and calcium antagonists (20) . on a morphological level, hepatic blood flow is mainly regulated at three different sites of resistance: at the terminal hepatic arterioles (21) ; at the arterioles of the splanchnic circulation (influencing the portal venous flow); and at the sinusoidal level, more specifically at the terminal hepatic venules (22) . under unphysiological conditions such as isolated liver HMP, information on the function of these auto-regulation mechanisms and the interaction between the flow in the HA and PV vascular beds are scarce. during ex vivo liver HMP conditions, all hepatic nerves are transected and the livers are perfused with a hypothermic acellular solution at perfusion pressures lower than in physiological in vivo conditions. Previously, we characterized the vascular resistance under such conditions and observed a gradual but remarkable decrease in the arterial Vr during the first 4 to 6 hours of HMP, while the portal Vr remained constant (9, 11) . the observation of flow competition, defined as a hampered or obstructed flow into the PV during HMP, was first occasionally observed during feasibility experiments, but could now be consistently evoked when a critical flow into the HA was reached. we hypothesized that this results from an increased Q HA . under the HMP settings as applied in our laboratory, the Liver workstation™ (organ recover Systems, chicago, uSA) for HMP is set to provide arterial perfusion at a constant pressure. normally, during perfusion at hypothermia, HA relaxation can be expected, resulting in an increased Q HA . An increased sinusoidal pressure can be a consequence of this vasorelaxation, despite the higher pressure losses along the HA tree due to the higher blood flow. Such an increased sinusoidal pressure could reduce the Q PV by decreasing the pressure drop between the PV and the sinusoids, thereby reducing the driving force for PV perfusion. this seems to make sense, as the P HA is higher compared to the P PV , and the hepatic natural flow regulation mechanisms, as described above, might be impaired or deficient during the reduced metabolic state of hypothermia. In another study, the blood circulation through a human liver was mathematically simulated using an electrical model (23). the results of this model illustrated the appearance of flow competition when us-during severe outflow obstruction, a distinctive pattern was observed, defined as a repetitive and alternating increase/decrease between Q HA and Q PV (tab. II, Figs. 3c  and d) . First, a decreasing Q PV was observed, while Q HA increased, then followed by a spontaneous restoration of Q PV with a decreasing Q HA . this flow competition pattern or interaction repeated itself and was eventually observed to be self-limiting. dIScuSSIon under normal physiological conditions, the hepatic blood flow is well-characterized. Approximately 1 mL of blood passes through 1 g of liver every minute (approximately 25-30% of the cardiac output) (15) . About 25% of the total hepatic blood flow is delivered by the HA, accounting for half of the oxygen supply to the liver. the remaining total hepatic blood flow and oxygen supply is provided by the PV. nevertheless, some significant physiological decreases in hepatic blood flow (related to sleep, exercise, and exhalation) or increases in hepatic blood flow (related to feeding, inhalation, and aging) are well-described in literature (15) (16) (17) . under in vivo conditions, intrinsic auto-regulation mechanisms guarantee a constant flow through the vascular bed by adaptations of the Vr, which is normally lower at the PV and higher at the HA. this auto-regulation takes place primarily in the HA vascular tree. the peri-vascular smooth muscle cell tone of the HA is mediated by stretching and adenosine concentrations. under normal conditions, adenosine is washed away by the portal flow. A decreased PV flow, resulting in higher levels of adenosine, induces a vasodilatation of the HA, which is followed by an immediate increase of arterial blood flow. this is referred to as the hepatic arterial buffer response (18) . An example of arterial flow decline in the case of portal hyperperfusion is observed in small or partial liver grafts displaying smallfor-size syndrome (SFSS). Indeed, in partial liver transplantation, liver grafts are subjected to a portal flow normally destined for a whole liver. consequently, portal flow is increased while arterial flow decreases (19) . In contrast to the previously described in vivo buffer response (where portal flow directly influences arterial flow), the ex vivo response observed in our study showed that arterial pressure/flow directly determines the portal flow. to our knowledge this has never been observed before.
these terminal hepatic arterioles and the sinusoids. consequently, the arterial flow will reach the sinusoids at a higher pressure. other possible explanations for our observations can be found in an increased flow through the arteriosinus twigs or in an increased resistance of the venous inlet sphincters. comparison of the flow competition evoked by P HA alterations and VcI obstructions reveals a clear difference. P HA increases led to competition in one direction: Q HA increased while Q PV decreased (Fig. 2) . In contrast, VcI obstructions affected both Q HA and Q PV in an alternating and repetitive fashion ( Fig. 3) . when theoretically interpreting the hepatic circulation as a passive system, the observation of flow competition evoked by an increased P HA would analogously lead to flow competition evoked by an increased P PV , leading to a decreased Q HA . However, we did not manage to evoke flow competition by increasing P PV . this can be explained by the fact that theoretically (as illustrated by the electrical model of the hepatic blood flow (23)), flow competition cannot be reached within the physiological ranges of P PV and Q PV by increasing the P PV . However, due to the absence of equipment to directly measure sinusoidal pressure and flow in an intact organ, our data do not allow the mechanisms of the observed flow competition to be analyzed more profoundly. As such, the roles of the potential factors contributing to flow competition discussed above are of a speculative nature. we emphasize that the flow competition phenomenon was also observed during HMP of human livers in our laboratory, supporting the clinical relevance of the observations made in the porcine model. the authors acknowledge that the model in its current format has some flaws (such as the lack of direct measurement of the sinusoidal pressure), but the observations made in this study showed that the flow competition could be consistently reproduced, justifying the nature of our hypothesis. these observations might have some important implications on the design and flow control for clinical, ex vivo machine perfusion devices. In this study we were not able to deduce a clear pressure/flow threshold that consistently triggers the flow competition in all porcine livers. this can be explained by the fact that every porcine liver has its individual anatomical features, and consequently, its unique physiological behavior. However, given the possibility of flow competition during HMP, we propose general guide-ing an increased P HA or obstructed VcI as boundary conditions. these results support our hypothesis that when changing the arterial flow, portal flow changes through an altered sinusoidal perfusion. Similar observations of flow competition, albeit in a different isolated perfusion model using cirrhotic rat livers, were made by Zipprich et al (24) . However, most studies concerning liver perfusion did not report any occurrence of flow competition between the HA and PV. table III shows an overview of liver perfusion studies and their corresponding perfusion conditions (species, HA and PV perfusion settings, temperature, perfusion period, pressure or flow control). to the best of our knowledge, and in contrast to our experience, none of these studies describes the exact flow and pressure profiles over time. comparing the perfusion setups of table III , it becomes clear that the hydrodynamics and settings are very different. For instance, no flow competition will be possible when using flow controlled perfusion, since by using those settings the flow is prescribed and not allowed to compete between the HA and PV. In addition, other parameters (such as the species studied, the application of high/low pressure/flow, different routes of perfusion (HA and/or PV), relatively short vs. longer periods of HMP studied, pulsatile or continuous perfusion, etc.) might also influence the occurrence of this phenomenon. Each of these parameters might play a role in whether or not triggering the initiation of flow competition, and consequently might be the reason why other groups possibly did not observe a similar competition phenomenon. to our knowledge, this ex vivo flow competition interaction has never been reported before. we speculate that this phenomenon results from an altered function of the presinusoidal sphincters at the level of the terminal hepatic arterioles. Such an alteration could be multi-factorial and induced by the denervation; the use of an acellular perfusion solution (essentially different from plasma, with an absence of humoral factors); the hypothermic conditions leading to a decreased metabolism and enzymatic activity; and the lack of oxygen and essential nutrients. denervation can probably be neglected as a possible cause, since hepatic denervation has been shown to have no major deleterious effects on hepatic blood flow after liver transplantation (20) . A factor which is more likely to contribute is the negative influence of the cold temperature (and concomitant intracellular energy depletion) on the pre-sinusoidal sphincters. this may eliminate the normal pressure drop between
